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ABSTRACT Isothermal titration calorimetry was used to characterize and quantify the partition of indomethacin and
acemetacin between the bulk aqueous phase and the membrane of egg phosphatidylcholine vesicles. Signiﬁcant electrostatic
effects were observed due to binding of the charged drugs to the membrane, which implied the use of the Gouy-Chapman
theory to calculate the interfacial concentrations. The binding/partition phenomenon was quantiﬁed in terms of the partition
coefﬁcient (Kp), and/or the equilibrium constant (Kb). Mathematical expressions were developed, either to encompass the
electrostatic effects in the partition model, or to numerically relate partition coefﬁcients and binding constants. Calorimetric
titrations conducted under a lipid/drug ratio[100:1 lead to a constant heat release and were used to directly calculate the
enthalpy of the process, DH, and indirectly, DG and DS. As the lipid/drug ratio decreased, the constancy of reaction enthalpy
was tested in the ﬁtting process. Under low lipid/drug ratio conditions simple partition was no longer valid and the interaction
phenomenon was interpreted in terms of binding isotherms. A mathematical expression was deduced for quantiﬁcation of the
binding constants and the number of lipid molecules associated with one drug molecule. The broad range of concentrations
used stressed the biphasic nature of the interaction under study. As the lipid/drug ratio was varied, the results showed that
the interaction of both drugs does not present a unique behavior in all studied regimes: the extent of the interaction, as well as
the binding stoichiometry, is affected by the lipid/drug ratio. The change in these parameters reﬂects the biphasic behavior
of the interaction—possibly the consequence of a modiﬁcation of the membrane’s physical properties as it becomes saturated
with the drug.
INTRODUCTION
Efﬁcient interaction with phospholipidic biological bilayers
and the ability to permeate cell membranes are parameters of
indubitable importance in the design, development, and
study of pharmacological active molecules. Historically,
these molecular characteristics were evaluated by the oct-
anol/water partition coefﬁcient (KO/W), which was used to
predict the degree of a drug’s afﬁnity to the lipid membrane
(Leo et al., 1971). Nevertheless, an isotropic bulk organic
solvent such as n-octanol is indeed unable to mimic the
structural and functional features of biological membranes,
and as a result the lack of KO/W/activity correlation is very
common (De Young and Dill, 1988).
The aim to get better membrane models led to the use of
several organized structures: cellular lines (involving very
time-consuming procedures), micelles (whose structure is
a poor bilayer membrane model), and mixed micelles,
monolayers, and liposomes (Betageri and Rogers, 1988).
Liposomes are phospholipidic vesicles, formed by one or
more concentric bilayers, offering a simple, but structurally
complete membrane model; these speciﬁc membrane
features can be isolated from other factors and studied
separately (Lasic, 1993).
The antiinﬂammatory, analgesic, and antipyretic drugs in-
domethacin and acemetacin are widely used in the treatment
of inﬂammatory and degenerative diseases. The mechanism
of action of these drugs is associated with the prostaglandin
synthesis inhibition, by interaction of the drugs with the
enzyme cyclooxygenase, which is involved in phospholipidic
metabolism (Vane, 1971). However, the nonsteroidal antiin-
ﬂammatory drugs (NSAIDs) have been associated with
serious adverse effects, especially those concerning the
gastrointestinal tract. Because the etiology of these gastroin-
testinal effects has recently been relatedwith the interaction of
the drugs with the membrane phospholipids (Lichtenberger
et al., 1995; Giraud et al., 1999; Srinath et al., 2000), drug
encapsulation in liposomes provides some degree of pro-
tection against these adverse effects. There are already in vivo
studies of preparations of indomethacin and acemetacin
associated with liposomes as pharmaceutical formulation
(Katare et al., 1995; Lichtenberger et al., 1996), which show
advantages in parameters like bioavailability and therapeutic
index, when compared with the free drug.
In this context, the evaluation and characterization of
indomethacin and acemetacin liposome association is a use-
ful step in the process of fully understanding the mechanism
of the drug’s interaction with the bilayer. Calorimetric
techniques have signiﬁcantly contributed to the understand-
ing of biological processes at molecular level. In this respect,
isothermal titration calorimetry (ITC) has proven a useful
technique, inasmuch as it allows the determination of
thermodynamic parameters for biological reactions with
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high sensibility and accuracy, at constant temperature (Freire
et al., 1990). The heat associated with the reaction is directly
measured, and related thermodynamic parameters, such as
enthalpy (DH), entropy (DS), and Gibbs free energy (DG),
can be calculated and used to quantify the extension and
energetics of the reaction under study. The data can be
treated to calculate the binding constant, Kb, and the binding
stoichiometry, n (Ba¨uerle and Seelig, 1991; Thomas and
Seelig, 1993; Milhaud et al., 1996; Rowe et al., 1998).
In this article, a study of the interaction of two NSAIDs
(indomethacin and acemetacin) with the membrane of neu-
tral liposomes, at pH 7.4 and 298.15 K, is presented. The
purpose of this study was to quantify the extent of the lipid/
drug association in a broad concentration range, and to
provide a thermodynamic analysis of the interaction.
MATERIALS AND METHODS
Materials
Egg phosphatidylcholine (EPC), indomethacin, and acemetacin were from
Sigma (St. Louis, MO), and used as received. All other chemicals were from
Merck (Darmstadt, Germany). Solutions were prepared with HEPES buffer
(10 mM, I ¼ 0.1 M, pH 7.4). The ionic strength was adjusted with NaCl.
The ﬂuorescent probe, n-(ﬂuorescein-5-thiocarbamoyl)-1,2-dihexadeca-
noyl-sn-glycero-3-phosphoetanolamine, triethylammonium salt (DHPE),
palmitoyl-oleoyl-phosphatidylcholine (POPC), and dimyristoyl-phosphati-
dylglycerol (DMPG) were from Avanti Polar Lipids (Alabaster, AL).
Vesicle preparation
Multilamellar vesicles (MLVs) were prepared by the thin ﬁlm hydration
method (Lasic, 1993), in which a lipid solution in chloroform/methanol was
evaporated to dryness with a stream of nitrogen. The resultant lipid ﬁlm was
hydrated with HEPES buffer and the mixture was vortexed at room
temperature (inasmuch as the transition temperature for EPC ranges from
158C to 78C; Tyrrell et al., 1976; New, 1990) to yield MLVs. Large
unilamellar vesicles (LUVs) were obtained from the MLV, by extrusion in
a 10-ml stainless-steel extruder (Lipex Biomembranes, Vancouver, BC,
Canada), maintained at constant temperature by a circulating water bath. The
liposome suspensions were passed 10 times through polycarbonate ﬁlters of
100-nm pore size (Nucleopore, Pleasanton, CA) under inert (N2) atmo-
sphere. Size distribution of the extruded vesicles was determined by quasi-
elastic light scattering analysis (Malvern ZetaSizer 5000, Malvern
Instruments, Malvern, Worcestershire, UK), using a helium-neon laser
(633 nm) as a source of incident light, operating at a scattering angle of 908
and a temperature of 258C. The mean particle size of the LUV was 141.56
5.8 nm (average and standard deviation of six independent measurements).
EPC concentration in the vesicle suspensions was determined by the
phosphomolibdate method (McClare, 1971).
Calorimetry
The calorimetric technique used was stepwise isothermal titration
microcalorimetry. The water bath and peripheral units were built at Lund
University (Lund, Sweden), and a twin heat conduction calorimeter
(ThermoMetric AB, Ja¨rfa¨lla, Sweden) was used with a 1-cm3 titration cell
equipped with a gold stirrer. The instrument was calibrated electrically,
using an insertion heater (Briggner and Wadso¨, 1991). The detailed
calorimetric procedure has been described previously (Bastos et al., 1997).
In each titration, 0.98486 0.0008 ml of sample (either liposome suspension
or drug solution) were placed in the titration cell and sequences of 20
successive 9.978 ml injections were made, at 298.15 K, at 4-min intervals
(injections with 20-min intervals did not reveal the presence of slow
reactions). Experiments were performed in the fast titration mode, the
resulting curves deconvoluted (Bastos et al., 1991), and the integrals
calculated with the program PSIGCALC (Sven Ha¨gg, Lund, Sweden). The
enthalpies were corrected for the dilution effects determined in separate
experiments.
Different types of experiments were performed, regarding the relative
positions of the drugs and the vesicles:
Type A1: drug solution in the syringe (1.2–4.3 mM), lipid suspension in
the cell (32–45 mM).
Type A2: drug solution in the syringe (1.2–4.3 mM), lipid suspension in
the cell (4–13 mM).
Type B: lipid in the syringe (40–46 mM), drug solution in the cell (0.75–
1.92 mM).
z-potential measurements
The vesicles z-potential was measured by quasielastic light scattering
analysis in the same instrument used for the diameter analysis (Malvern
ZetaSizer 5000). The measurements were performed in a ZET 5104 cell, at
a temperature of 298 K (25.08C), and a scattering angle of 908. The solvent
viscosity and refractive index values were 0.890 cP and 1.330, respectively
(apparatus default).
Fluorescence measurements
Fluorescence spectra were obtained using a SPEX Fluorolog 212 system
(Spex CertiPrep, Metuchen, NJ) at a right-angle geometry. The excitation
wavelength was set to 488 nm (DHPE absorption maximum) and the
emission covered the spectra from 400 to 600 nm (emission maximum;510
nm) The aqueous pH was measured with a combined Orion Ross glass
electrode in a Orion 720A pH-meter (Thermo Electron, Beverly, MA).
MODELS AND DATA ANALYSIS
When a solute A is in the presence of two nonmiscible
phases (in this case, aqueous and lipid phases), it distributes
between the two according to its afﬁnity to each medium.
This afﬁnity can be quantiﬁed in terms of a partition
coefﬁcient,
Kp ¼ ½Am=Vm½Aw=Vw 
½Am
½Aw½LVF ; (1)
where the subscripts w and m stand for aqueous- and
membrane-bound species, Vm and Vw for lipid and aqueous
solution volumes, [L] for lipid concentration, and Vf for the
lipid molar volume. All concentrations are expressed as
a function of total suspension volume. As the lipid molar
volume is not always known, the partition coefﬁcient, Kp,
can also be expressed in M1, being Kp (in M
1) ¼ Vf Kp
(dimensionless). In the present text we will be using Kp
expressed in M1.
Besides this simple-partition model, the distribution of
a solute between the two immiscible phases can also be
regarded as a drug-lipid association. The association con-
stant, Kb, for the binding equilibrium
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Aw1 L ! Am (2)
is given by (Berezin et al., 1973)
Kb ¼ ½Am½Awð½L  ½AmÞ ; (3)
where the symbols have the same meaning as above. If the
drug concentration is much lower than the lipid concentra-
tion, the equilibrium free lipid concentration is practically
equal to the initial lipid concentration and in this case, Kb 
Kp. Therefore, although conceptually different, the mathe-
matical expressions for partition and association are
equivalent, under these conditions.
In experimental conditions where the lipid/drug concen-
tration ratio is lower, additional effects can invalidate the
partition model due to interactive phenomena, such as
electrostatic effects (if the drug is charged) (Matos et al.,
2004) or saturation of the membrane (Milhaud et al., 1996;
Dimitrova et al., 2000).
Determination of the enthalpy of reaction
When the concentration of added drug is kept very small
(lipid/drug ratio [100:1), the heat effect is practically
constant in each addition of drug. The area under each peak
gives the amount of heat released after injection i, qi, and it
can be easily related to the reaction enthalpy (DH), by
(Breslauer et al., 1992; Freire et al., 1990)
DH ¼ qi=nm;i; (4)
where nm,i is the number of moles of drug bound per
injection.
Partition model
From Eqs. 1 and 4, an expression can be deduced, relating
the binding polynomial to the heat released (for the case
where the drug is being titrated with lipid),
Qi ¼ nTDH Kp½Li
11Kp½Li
; (5)
where nT represents the total number of moles of drug
present in the system, equal to the sum of bound (nm) and
free drug (nw); and [L]i, which is the lipid concentration in
the cell after each injection.
Consideration of electrostatic effects
When dealing with charged drugs and when the lipid/drug
ratio in the system is signiﬁcantly low, as in the case of
titration of drug solution with lipid suspension, the
electrostatic contribution cannot be neglected. If the
phospholipidic membrane is initially neutral, the partition
of a negatively charged species will lead to a charging up of
the membrane. This implies that the concentration of the
charged drug at the interface ([Ai
]) will be lower than its
bulk concentration ([Aw
]). The interface concentration can
be related to the bulk concentration by the Boltzmann
equation (McLaughlin and Harary, 1976),
½Ai  ¼ ½Aw  expðziFC0=RTÞ; (6)
where C0 is the surface potential, zi is the valence of the ion
(1), and F, R, and T have the usual meanings.
Correction of Eq. 5 with Eq. 6 allowed us to establish
a relationship between the heat released and lipid concen-
tration, but where the interfacial concentration of the drug is
taken into account,
Qi ¼ nTDH Kp expðziFC0=RTÞ½L
11Kp expðziFC0=RTÞ½L : (7)
Determination of the surface potential (W0)
The surface potential (C0) can be obtained in a number of
different methodologies. In the present work we used three
methods to obtain C0, as follows.
Method a
Direct experimental determination of z-potential values
(Cx) of the liposomes, as described in the experimental
part, for different drug and lipid concentrations, and
calculation of C0 according to
C0 ¼ 2kT
e
ln
11a
1 a (8)
and
a ¼ expðeCx=2kTÞ  1
expðkxÞ½expðeCx=2kTÞ1 1 ; (9)
where k is the Boltzmann constant, e is the electron
charge, k is the reciprocal of the Debye screening
length, and a is a parameter dependent on the value of
C0 (the mathematical formalism is described further in
Matos et al., 2004).
Method b
Theoretical calculation of the surface charge density, s,
as described by Seelig and his co-workers (Ba¨uerle and
Seelig, 1991; Thomas and Seelig, 1993),
s ¼ nme0=ðnmaD1 nLaLÞ; (10)
where aL is the surface area of the lipid molecule, aD is
the surface area of the drug molecule, nm is the number
of moles of bound drug, and nL the total number of
moles of lipid. The lipid surface area, aL ¼ 68 A˚2, was
taken from the literature (Ba¨uerle and Seelig, 1991;
Beschiaschvili and Seelig, 1992), and the surface areas
for the two drugs were calculated in QUANTA
(QUANTA version 00.1110, 2000, Molecular Simula-
tions, Burlington, MA), using a probe of 0.5 A˚2. The
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values obtained were 59.6 A˚2 for acemetacin and 30.6
A˚2 for indomethacin. From the nm values obtained from
the calorimetric titration, the experimental surface
charge density was calculated according to Eq. 10.
The surface potential can then be calculated from the
Gouy-Chapman theory by (McLaughlin et al., 1971)
s
2 ¼ 2000ere0RT S ci½expðziFC0=RTÞ  1: (11)
The values for the surface potential C0 were then
obtained by computer ﬁtting, matching the experimen-
tally derived surface charge density with the corre-
sponding values predicted from the Gouy-Chapman
theory.
Method c
Experimental determination of the surface potential
values (C0) by the use of a ﬂuorescent probe. The
apparent pKa of a lipophilic probe in the vesicle
suspension, pKobsa , can be related with C0 by the
following equation (Mukerjee and Banerjee, 1964;
Fernande´z, 1981; Fromherz, 1989),
pK
obs
a ¼ pK0a  FC0=2:3RT; (12)
where pK0a is the pKa when s ¼ 0, and, consequently,
C0 ¼ 0. The pK0a is an intrinsic pKa of the molecule in
the interface region, and must be ascertained in the same
local conditions that exist in the charged interface.
The calibration of the pKobsa versus C0 was done using
POPC as the neutral phospholipid system ðpK0aÞ and
mixtures of POPC/DMPG with increasing amounts of
charge (Lukac, 1983). From previous experiments we
knew that in these mixtures the charged component,
DMPG, is randomly distributed in the vesicles; thus we
can assume a homogeneous distribution of charges
within the bilayers.
The values of pKobsa for the ﬂuorescent probe DHPE were
determined by ﬂuorescence, ﬁtting the intensity as
a function of the aqueous pH, as stated by the equation
pKobsa ¼ pH logða=1 aÞ with a ¼ (FFAH1)/
(FAFAH1), where F is the ﬂuorescence intensity at
the band maximum of the conjugate acid-base forms
at the particulate pH being examined. FAH1 and FA are
the ﬂuorescence intensities at the same wavelength at
pH values such that only AH1 or A exist (Garcı´a-Soto
and Fernande´z, 1983).
The values of pKa
obs were determined in the lipid
dispersions in different drug concentrations and used to
calculate the C0 values using Eq. 12.
Multiple independent binding sites model
The multiple independent binding sites model (Freire et al.,
1990; Breslauer et al., 1992) assumes that the drug molecule
possesses n independent binding sites, all with the same
afﬁnity for the lipid molecule (Turner et al., 1995). The
binding constant, Knb; quantiﬁes the association of one lipid
molecule to one binding site in the drug molecule. Although
a real binding in the usual strict sense is not applicable in
lipid/drug association, the use of this conceptual model is
useful as it provides us with the lipid/drug association
number, n. Being that nL is the total number of moles of lipid
present in the system, Eq. 3 will now be expressed as
K
n
b ¼
n3 nm
n½AwðnL  n3 nmÞ (13)
Considering Eq. 4 we have deduced Eq. 14,
Qi ¼ nLDH K
n
b ½Aw
11 nKnb ½Aw
: (14)
To relate the obtained binding constant, Kb
n, with the
partition coefﬁcient, Kp, we have deduced Eq. 15,
Kp ¼ K
n
b
11 nKnb ½Aw
: (15)
As the concentration of drug in the cell is always\103 M,
in practical terms the free drug concentration, [Aw], is
relatively small, being n 3 Kb 3 [Aw]  1, so Knb  Kp:
RESULTS AND DISCUSSION
Calorimetric titration of liposome suspensions
with drug solutions
In titrations of type A1 (see Materials and Methods), lipid/
drug concentration ratio in the titration cell was kept
[100:1. In this experimental condition, the heat release
was constant, and allowed the calculation of the enthalpy
change, per mole of drug added, by Eq. 4 (Bains and Freire,
1991; Ba¨uerle and Seelig, 1991; Seelig and Ganz, 1991;
Beschiaschvili and Seelig, 1992; Thomas and Seelig, 1993;
Terzi et al., 1994; Seelig et al., 1996; Schote and Seelig,
1998; Wenk and Seelig, 1998).
A typical calorimetric tracing of the injection of aliquots of
drug solution into liposome suspensions can be seen in Fig. 1.
The number of moles of bound drug, nm, was calculated
assuming the drug’s partition coefﬁcients (previously de-
termined) as 791 M1 and 2465 M1 in MLV (Castro et al.,
2001a) and 992 M1 and 1527 M1 in LUV (Castro et al.,
2001b), for indomethacin and acemetacin, respectively.
These values of partition coefﬁcients quantify an almost
complete binding of both drugs to the membrane (96–99%),
considering the lipid concentration and the pH used. The
results were nevertheless corrected according to the obtained
percentage of bound drug in each case. From the determined
values of DH, the values DS and DG were calculated and
results are presented in Table 1.
To evaluate the possibility of concomitant phenomena
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such as drug aggregation or micellization, solutions of each
drug were injected into buffer, and no measurable heat
change was detected—an indication that no feature other
than drug partition is being measured.
In titrations of type A2 (see Materials and Methods; the
lipid/drug ratio is lower (between 150:1 and 6:1), and
constant partition of the drug between water and lipid media
can no longer be guaranteed, because concomitant saturation
or electrostatic effects interfere in the process. The injection
of aliquots of drug solution in a LUV suspension originates
a series of decreasing heat releases, as can be observed in
Fig. 2.
The amount of drug that has interacted with the lipid
membrane after each injection can be calculated from the
heat released, knowing DH and using Eq. 4. If a partition
mechanism was to be considered, a linear relation would be
expected between the bound fraction, Xb (given by the ratio
of the bound drug moles, nm, to the total number of lipid
moles, nL) and the amount of free drug in the aqueous media,
[Aw] (Ba¨uerle and Seelig, 1991; Thomas and Seelig, 1993;
Seelig et al., 1996; Schote and Seelig, 1998; Wenk and
Seelig, 1998). Results show, however, that less drug is taken
up at higher concentrations than expected for simple
partitioning. Plots of Xb versus [Aa] were constructed for
both drugs, as exempliﬁed in Fig. 3, and do not show a linear
relationship.
The decrease in drug uptake throughout the titration can
be explained by several simultaneous phenomena, such as
saturation of the lipid membrane (Ramsay et al., 1986; Myers
et al., 1987), electrostatic effects due to the binding of a
charged molecule to the membrane (Lehrmann and Seelig,
1994), or even decrease of DH throughout the titration as
a result of the change in the nature of the interaction (Ramsay
et al., 1986).
Actually, the partition coefﬁcient, named under these
conditions the apparent partition coefﬁcient (Schote and
Seelig, 1998), decreases throughout the titration. For
indomethacin, the apparent partition coefﬁcient decreases
from 869 M1 to 186 M1 from the ﬁrst to the last injection,
whereas for acemetacin a decrease from 2224 M1 to 374
M1 is observed. Apparently, a saturation of the membrane
FIGURE 2 Titration of a suspension of LUV (4 mM) with an acemetacin
solution (3.2 mM) in HEPES buffer at 298.15 K. Each peak corresponds to
a 9.978 ml injection. Lipid/drug ratio ranged from 120:1 to 6:1 at the end of
the titration.
FIGURE 1 Titration of a suspension of LUV (45 mM) with an acemetacin
solution (2.7 mM) in HEPES buffer at 298.15 K. Each peak corresponds to
a 9.978 ml injection. Lipid/drug ratio ranged from 1500:1 to 80:1 at the end
of the titration. The reaction is exothermic and the reaction enthalpy is
constant because the lipid is in large excess over the added drug.
TABLE 1 Values of DH calculated from the experimental
data obtained in the titration of a concentrated lipid suspen-
sion (32–45 mM) with a drug solution (1.2–4.3 mM)
Liposome
type Drug
DH
(kJ.mol1)
DG
(kJ.mol1)
TDS
(kJ.mol1)
LUV Indomethacin 17.3 (2.2) 17.3 (0.2) 0 (2.0)
Acemetacin 19.7 (1.1) 18.9 (0.5) 0.8 (1.5)
MLV Indomethacin 14.2 (1.9) 16.5 (0.2) 2.3 (2.0)
Acemetacin 17.8 (2.0) 19.4 (0.2) 1.6 (2.0)
Values of DG and TDS were calculated by the trivial thermodynamic
relationships: DG ¼ RT ln Kb and DG ¼ DH TDS. Values in
parentheses are the standard deviations.
FIGURE 3 Plot of Xb versus [Aa] for acemetacin. Results of the titration of
a suspension of LUV (4 mM) with an acemetacin solution (3.2 mM) in
HEPES buffer.
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is taking place, as observed by Seelig and his co-workers
(Ba¨uerle and Seelig, 1991; Thomas and Seelig, 1993; Seelig
et al., 1993). These authors used the Gouy-Chapman theory
to correct the data for electrostatic effects, and were able to
determine the true partition constant (Thomas and Seelig,
1993). However, the use of the same mathematical formal-
ism (see Determination of the Surface Potential,Method b) to
our data did not lead to a complete linearization of the Xb vs.
[Ai] plots. The same is even more apparent in the calculations
done with the drug’s surface concentration calculated with
the surface potential derived from the ﬂuorescence method
(see Determination of the Surface Potential, Method c; see
also Fig. 4, a and b).
Fitting our results with ﬁxed or varying DH shows that its
value does not change signiﬁcantly from the values in Table
1. Therefore, the observed decrease in heat release is pos-
sibly not related to a variation on DH value, but to parallel
saturation phenomena.
To determine the stoichiometry of the reaction, n, the
results were then evaluated by the multiple independent
binding sites model (Eq. 14), but considering the interfacial
concentrations, calculated according to Eq. 6. Nonlinear
ﬁtting of Eq. 14 was achieved only if two ﬁtting zones were
considered: the ﬁrst encompassing the ﬁrst 10 points of the
titration and the second the latter 10. Fittings can be observed
for acemetacin in Fig. 5.
The value of DH was ﬁxed as 19.7 kJ/mol for
acemetacin and 17.3 kJ/mol for indomethacin (note that
ﬁttings performed without ﬁxing the value of DH yielded
similar results). Results are depicted in Table 2. Three
methodologies were used to calculate the surface potential,
and a comparison between the results obtained (unpublished
material). The three methodologies used to calculate the
surface potential yielded similar ﬁtting results. As an ex-
ample, we include in Table 2 the values obtained by the three
methodologies for the case of acemetacin. This kind of ag-
reement was obtained throughout. In view of this agreement,
the results presented hereafter will only be those obtained by
use of the values of C0 obtained from z-potential measure-
ments.
As presented in Table 2, the interaction of both drugs with
the lipid membrane appears to be of a biphasic nature. For
lower concentrations of drug, the binding constant is higher,
whereas for lower lipid/drug ratio the process behavior
apparently changes, with the drug having a lower afﬁnity for
the lipid as assessed by the decrease in Kb. The value of n
also decreases, suggesting that the binding stoichiometry
changes with the increase in bound drug. The turning-point
happens at a lipid/drug ratio of 12:1 for acemetacin and 17:1
for indomethacin.
One can infer that once this ratio has been surpassed, the
amount of drug in the membrane changes its composition
and, consequently, its physical characteristics, which is
reﬂected in a different association with the drug added
afterwards. This interpretation is not new; an alteration of the
interaction behavior during incorporation of a solute in
organized systems has been reported previously, either with
lipid membranes (Schuster et al., 1975) or micelles (Lissi and
FIGURE 4 Plot of Xb versus [Ai] for acemetacin. Results of the titration of
a suspension of LUV (4 mM) with an acemetacin solution (3.2 mM) in
HEPES buffer. In a, the surface potential is calculated from the ﬂuorescence
method, and in b, from the Gouy-Chapman theory (Eqs. 6, 8, and 9).
FIGURE 5 Fitting of the multiple independent binding sites model (Eq.
14) to the experimental data obtained from the titration of a suspension of
LUV (4 mM) with an acemetacin solution (3.2 mM) in HEPES buffer. The
value of DH was ﬁxed at 19.7 kJ/mol.
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Abuin, 1983). Recently, Coutinho and Prieto (2003) de-
scribed a concentration-dependent cooperative partition of
nystatin to liposomes. In particular, ITC technique has been
used to characterize biphasic type binding of solutes to lipid
membranes (Zachowski and Durand, 1988; Dimitrova et al.,
2000).
Calorimetric titration of drug solutions with
liposome suspensions
In titrations of type B (see Materials and Methods; lipid/drug
ratio ranged between 0.3 and 6. An example of the re-
sults obtained from these titrations can be observed in Fig. 6.
With the progress of the titration, less and less free drug in
solution is available for interacting, resulting in a decrease in
the heat released (Terzi et al., 1994; Seelig et al., 1996;
Schote and Seelig, 1998). The height of the individual
titration peaks is correlated with the ligand concentration,
whereas the steepness of the decrease depends primarily on
the lipid concentration and the binding constant (or partition
coefﬁcient; see Wenk et al., 1997).
Plots of Xb versus [Aa] (i.e., free drug concentration in the
bulk, with no correction for electrostatic effects) did not yield
a linear correlation; besides, nonlinear ﬁtting of the simple-
partition model expressed by Eq. 5 (which is mathematically
equivalent to the Xb vs. [Aa] model) result in lack of ﬁt
(results not shown). The lack of success of such approaches
is explained by the strong electrostatic interference, due to
the high proportion of a charged ligand interacting with the
lipid.
The experimental data were ﬁt with Eq. 7, which accounts
for electrostatic correction of the data; the ﬁt is displayed in
Fig. 7.
The good ﬁt obtained with this model implies that the
electrostatic effects were satisfactorily corrected. The results
of Kp (or Kb) in LUV obtained were 432 6 19 M
1 for
acemetacin and 3506 42 M1 for indomethacin. If both DH
and Kp are allowed to vary, the following set of results are
obtained. For acemetacin, DH ¼ 17.7 6 0.3 kJ/mol and
Kp¼ 5306 37M1 and for indomethacin,DH¼15.36 0.7
kJ/mol and Kp ¼ 414 6 12 M1. In this case, signiﬁcantly
smaller values are obtained for DH when it is allowed to
vary. This is a further indication that we have in this case
a highly perturbed membrane, due to the excess of drug
present.
CONCLUSIONS
An important objective in the design of pharmacological
active compounds is their ability to efﬁciently permeate and
interact with biological lipid membranes, from which can
depend either pharmacological or adverse effects of the drugs.
The study and characterization of such drug/membrane
interactions can lead to important assessments related to the
drugs’ action in biological media. As stated, the interaction of
FIGURE 6 Titration of an acemetacin solution (1.6 mM) with a suspen-
sion of LUV (40 mM) in HEPES buffer at 298.15 K. Each peak corresponds
to a 9.978 ml injection. Lipid/drug ratio in the titration cell ranged from
0.28:1 to 5.6:1 at the end of the titration.
FIGURE 7 Fitting of the electrostatic corrected partition model (Eq. 7) to
the experimental data obtained from the titration of acemetacin (squares) or
indomethacin (circles) with a suspension of LUV in HEPES buffer. The
value of DH was ﬁxed at19.7 kJ/mol for acemetacin and17.3 kJ/mol for
indomethacin.
TABLE 2 Values of binding constants, Kb, and number of
lipid binding sites, n, obtained from ﬁtting Eq. 14 to the
experimental data collected from the titrations of LUV
suspensions (4–13 mM) with drug solution
Drug Fitting range Kb
n (M1) n
Indomethacin First 10 data 530 (43) 8.5 (2.9)
Last 10 data 450 (24) 4.9 (1.3)
Acemetacin First 10 data 2594 (198) 10.4 (0.8)
2416 (196)* 11.2 (0.8)*
2535 (165)y 8.0 (0.8)y
Last 10 data 1110 (27) 1.6 (0.3)
Values in parenthesis are standard deviations obtained from the ﬁtting.
Values not marked were obtained with the interface drug concentration
calculated by use of the surface potential calculated from the z-potential
results.
*Values calculated with the surface potential determined by ﬂuorescence
(Method c).
yValues calculated with the theoretical surface potential (Method b).
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both indomethacin and acemetacin with the lipid bilayer is
exothermic. Further, the enthalpy is the driving force for the
interaction, as the entropy variation is close to 0 for both
drugs. The results point out that the interaction of these drugs
can be classiﬁed, as suggested by Seelig et al. (Ba¨uerle and
Seelig, 1991), as the nonclassical hydrophobic effect, usually
observed in the interaction of solutes with lipid membranes.
In titrations performed under experimental conditions in
which the lipid/drug ratio is low, saturation phenomena are
observed, and the apparent partition coefﬁcients are lower
than the real partition coefﬁcient. Application of the multiple
independent binding sites model leads to the ﬁnding of
a biphasic nature for these interactions. In fact, a modiﬁcation
of the membrane’s physical properties apparently occurs as
the membrane becomes saturated with the ligand, with a
corresponding change in the values of the binding constant
and the stoichiometry. Such modiﬁcation in the membrane
appears to take place at lipid/drug ratio of 12:1 for acemetacin
and 17:1 for indomethacin. This assertion agrees with
published results that describe a modiﬁcation on the structure
of the bilayer caused by indomethacin, assessed bydifferential
scanning calorimetry studies (Bonina et al., 1994; Castelli
et al., 1997).
Therefore, the use, in this study, of lipid/drug ratios that
ranged between 1500:1 and 0.28:1 (taking all titrations
effectuated) allowed us to verify the inconstancy of the
extent and stoichiometry of the interaction under study, and
infer that the binding of the drug to the molecule actually
induces physical and structural changes in the lipid
membrane.
At this point, some additional remarks should be made.
Firstly, a word about the binding/partition approach de-
veloped in this work: the interaction of a solute with
a dispersed lipid phase is conceptually related to a Nernstian
distribution between two nonmiscible liquids. By this ap-
proach, only a partition of the solute is conceptually valid,
and all the parameters contributing to the interaction
extent—electrostatic, hydrophobic, steric, etc.—are enclosed
in the notion of partition and globally quantiﬁed. Moreover,
all these parameters are assumed to be nonvariable with
changes in concentration. On the other hand, the consider-
ation of a binding mechanism between the solute and the
lipid describes the existence of binding sites in the
membrane, receptor-like locals that accommodate the ligand.
By its very nature the basic homogeneous distribution of the
phospholipid molecules throughout the bilayer is not com-
pletely agreeable with this receptor nature of the membrane,
and has been refuted by other authors.
Nevertheless, in this work, and to our knowledge for the
ﬁrst time, the two approaches of binding and partition have
been complementarily used to fully describe a drug/lipid
interaction. We have noticed that, for a wide range of lipid/
drug ratios, the partition concept is adequate as long as we
correct for electrostatic effects; but when different lipid/drug
proportions are spanned, the saturation and electrostatic ef-
fects, or even membrane structural changes, are increasingly
contributing to the overall interaction and this phenomenon
can no longer be interpreted in terms of a simple partition.
In this case, the process is better described by a binding iso-
therm, characterized by a number of lipid molecules associ-
ated with each drug molecule and by a binding constant.
The introduction of the parameter n allowed ﬂexibility into
the binding curve, and showed that there actually was a
change in association number along the binding isotherm,
which is a parameter not possible to envisage in a simple
partition model.
A second point to be stressed could be the need for
enlarging the range of analytical concentrations under study,
which allows concentration-dependent features to be put in
evidence. In fact, one of the main advantages attributed to the
ITC technique is the possibility of covering a wide range of
concentrations. For other methods, such as spectroscopic,
this constitutes a limitation; and the conclusions to be drawn
from the data obtained are only a snapshot of a particular
state of the interaction under study.
M.B. thanks Dr. Elsa Henriques for the calculation of the drugs’ surface
areas.
Thanks are due to Fundac¸a˜o para a Cieˆncia e Tecnologia for ﬁnancial
support to Centro de Investigac¸a˜o em Quı´mica da Universidade do Porto,
Research Unit 81; thanks also to Fundo Europeu de Desenvolvimento
Regional (POCTI/FCB/47186/2002) and to PRAXIS (XXI/BPD/16373/98)
(A.L.) for ﬁnancial support.
REFERENCES
Bains, G., and E. Freire. 1991. Calorimetric determination of cooperative
interactions in high afﬁnity binding processes. Anal. Biochem. 192:203–
206.
Bastos, M., M. Afonso, M. H. M. Cac¸ote, and M. J. Ramos. 1997.
Interactions in the model system a-cyclodextrin-glycerol. Experimental
and theoretical study. J. Chem. Soc. Faraday Trans. 93:2061–2067.
Bastos, M., S. Ha¨gg, P. Lo¨nnbro, and I. Wadso¨. 1991. Fast titration
experiments using heat conduction microcalorimeters. J. Biochem.
Biophys. Meth. 23:255–258.
Ba¨uerle, H., and J. Seelig. 1991. Interaction of charged and uncharged
calcium channel antagonists with phospholipid membranes. Binding
equilibrium, binding enthalpy, and membrane location. Biochemistry.
30:7203–7211.
Berezin, I. V., K. Martinek, and A. K. Yatsimirskii. 1973. Physicochemical
foundations of micellar catalysis. Russ. Chem. Rev. 42:787–802.
Beschiaschvili, G., and J. Seelig. 1992. Peptide binding to lipid bilayers.
Nonclassical hydrophobic effect and membrane-induced pK shifts.
Biochemistry. 31:10044–10053.
Betageri, G. V., and J. A. Rogers. 1988. The liposome as a distribution
model in QSAR studies. Int. J. Pharm. 46:95–102.
Bonina, F. P., F. Castelli, L. Montenegro, and G. Mazzone. 1994.
Partitioning and differential scanning calorimetry studies of n-alkylac-
tame ester dermal prodrugs of indomethacin. Int. J. Pharm. 106:115–
123.
Breslauer, K. J., E. Freire, and M. Straume. 1992. Calorimetry: a tool for
DNA and Ligand-DNA studies. Meth. Enzymol. 211:533–563.
Briggner, L.-E., and I. Wadso¨. 1991. Test and calibration processes for
microcalorimeters, with special reference to heat conduction instruments
used with aqueous systems. J. Biochem. Biophys. Meth. 22:101–118.
Calorimetry of NSAIDs with Liposomes 953
Biophysical Journal 86(2) 946–954
Castelli, F., B. Conti, D. Maccarrone, O. Camera, and U. Conte. 1997.
Indomethacin-dipalmitoylphosphatidylcholine interaction. A calorimetric
study of drug release from poly (lactide-co-glycolide) microspheres into
multilamellar vesicles. Drug Del. 4:273–279.
Castro, B., P. Gameiro, J. L. F. C. Lima, C. Matos, and S. Reis. 2001a.
A fast and reliable spectroscopic method for the determination of
membrane-water partition coefﬁcients of organic compounds. Lipids.
36:89–96.
Castro, B., P. Gameiro, J. L. F. C. Lima, C. Matos, and S. Reis. 2001b.
Location and partition coefﬁcients of antiinﬂammatory drugs in EPC
liposomes. A ﬂuorescence quenching study using n-(9-antroyloxy)-
stearic probes. Coll. Surf. A. 190:205–212.
Coutinho, A., and M. Prieto. 2003. Cooperative partition model of nystatin
interaction with phospholipid vesicles. Biophys. J. 84:3061–3078.
De Young, L. R., and K. A. Dill. 1988. Solute partitioning into lipid bilayer
membranes. Biochemistry. 27:5281–5289.
Dimitrova, M. N., H. Matsumura, A. Dimitrova, and V. Z. Neitchev. 2000.
Interaction of albumins from different species with phospholipid
liposomes. Multiple binding sites system. Int. J. Biol. Macromol. 27:
187–194.
Fernande´z, M. 1981. Determination of surface potential in liposomes.
Biochim. Biophys. Acta. 646:23–26.
Freire, E., O. L. Mayorga, and M. Straume. 1990. Isothermal titration
calorimetry. Anal. Chem. 62:950A–958A.
Fromherz, P. 1989. Lipid coumarin dye as a probe of interfacial electrical
potential in biomembranes. Methods Enzymol. 171:376–387.
Garcı´a-Soto, J., and M. Fernande´z. 1983. The effect of neutral and charged
micelles on the acid-base dissociation of the local anesthetic tetracaine.
Biochim. Biophys. Acta. 731:275–281.
Giraud, M., C. Motta, J. J. Romero, G. Bommelaer, and L. M.
Lichtenberger. 1999. Interaction of indomethacin and naproxen with
gastric surface-active phospholipids: a possible mechanism for the gastric
toxicity of nonsteroidal anti-inﬂammatory drugs (NSAIDs). Biochem.
Pharmacol. 57:247–254.
Katare, O. P., S. P. Vyas, and V. K. Dixit. 1995. Enhanced in vivo
performance of liposomal indomethacin derived from effervescent
granule based proliposomes. J. Microencapsul. 12:487–493.
Lasic, D. D. 1993. Liposomes—From Physics to Applications. Elsevier,
Amsterdam, The Netherlands.
Lehrmann, R., and J. Seelig. 1994. Adsorption of Ca21 and La21 to bilayer
membranes: measurement of the adsorption enthalpy and binding
constant with titration calorimetry. Biochim. Biophys. Acta. 1189:89–95.
Leo, A., C. Hansch, and D. Elkins. 1971. Partition coefﬁcients and their
uses. Chem. Rev. 71:525–552.
Lichtenberger, L. M., C. Ulloa, J. J. Romero, A. L. Vanous, P. A. Illich, and
E. J. Dial. 1996. Nonsteroidal anti-inﬂammatory drug and phospholipid
prodrugs: combination therapy with antisecretory agents in rats.
Gastroenterology. 111:990–995.
Lichtenberger, L. M., Z. Wang, J. J. Romero, C. Ulloa, J. C. Perez, M.
Giraud, and J. C. Barreto. 1995. Non-steroidal anti-inﬂammatory drugs
(NSAIDs) associate with zwitterionic phospholipids: insight into the
mechanism and reversal of NSAID-induced gastrointestinal injury. Nat.
Med. 1:154–158.
Lissi, E., and E. Abuin. 1983. Partitioning of normal-hexane and normal-
heptane in micellar solutions of sodium dodecyl sulphate. J. Coll. Inter.
Sci. 95:198–203.
Lukac, S. 1983. Surface potential at surfactant and phospholipid vesicles as
determined by amphiphilic pH indicators. J. Phys. Chem. 87: 5045–
5050.
Matos, C., B. Castro, P. Gameiro, J. L. C. Lima, and S. Reis. 2004. Zeta-
potential measurements as a tool to quantify the effect of charged drugs
on the surface potential of EPC liposomes. Langmuir. In press.
McClare, C. W. F. 1971. An accurate and convenient organic phosphorus
assay. Anal. Biochem. 39:527–530.
McLaughlin, S. G. A., G. Szabo, and G. Eisenman. 1971. Divalent ions and
the surface potential of charged phospholipid membranes. J. Gen.
Physiol. 58:667–687.
McLaughlin, S., and H. Harary. 1976. The hydrophobic adsorption of
charged molecules to bilayer membranes: a test of the applicability of the
Stern equation. Biochemistry. 15:1941–1948.
Milhaud, J., J. M. Lancelin, B. Michels, and A. Blume. 1996. Association
of polyene antibiotics with sterol-free lipid membranes. I. Hydrophobic
binding of ﬁlipin to dimyristoylphosphatidylcholine bilayers. Biochim.
Biophys. Acta. 1278:223–232.
Mukerjee, P., and K. Banerjee. 1964. A study of the surface pH of micelles
using solubilized indicator dyes. J. Phys. Chem. 68:3567–3574.
Myers, M., O. L. Mayorga, J. Emtage, and E. Freire. 1987. Thermodynamic
characterization of interactions between ornithine transcarbamylase
leader peptide and phospholipid bilayer membranes. Biochemistry. 26:
4309–4315.
New, R. R. C. 1990. Liposomes—A Practical Approach. D. Rickwood and
B. D. Hames, editors. IRL Press, Oxford, UK.
Ramsay, G., R. Prabhu, and E. Freire. 1986. Direct measurement of the
energetics of association between myelin basic protein and phosphati-
dylserine vesicles. Biochemistry. 25:2265–2270.
Rowe, E. S., F. Zhang, T. W. Leung, J. S. Parr, and P. T. Guy. 1998.
Thermodynamics of membrane partitioning for a series of n-alcohols
determined by titration calorimetry: role of hydrophobic effects. Bio-
chemistry. 37:2430–2440.
Schote, U., and J. Seelig. 1998. Interaction of the neuronal marker dye
FM1–43 with lipid membranes. Thermodynamics and lipid ordering.
Biochim. Biophys. Acta. 1415:135–146.
Schuster, J., C. Fleschurz, and I. Helm. 1975. On the interaction of
a lipophilic drug with different sites of rat-liver microsomes. Equilibrium
studies with a substituted pleuromutilin. Eur. J. Biochem. 51:511–519.
Seelig, A., T. Alt, S. Lotz, and G. Ho¨lzemann. 1996. Binding of substance
P agonists to lipid membranes and to the neurokinin-1 receptor.
Biochemistry. 35:4365–4374.
Seelig, J., and P. Ganz. 1991. Nonclassical hydrophobic effect in membrane
binding equilibria. Biochemistry. 30:9354–9359.
Seelig, J., S. Nebel, P. Ganz, and C. Bruns. 1993. Electrostatic and
nonpolar peptide-membrane interactions. Lipid binding and functional
properties of somatostatin analogues of charge z ¼ 11 to z ¼ 13.
Biochemistry. 32:9714–9721.
Srinath, P., S. Vyas, and P. Diwan. 2000. Preparation and pharmacody-
namic evaluation of liposomes of indomethacin. Drug Dev. Ind. Pharm.
26:313–321.
Terzi, E., G. Ho¨lzemann, and J. Seelig. 1994. Alzheimer b-amyloid peptide
25–35: electrostatic interactions with phospholipid membranes. Bio-
chemistry. 33:7434–7441.
Thomas, P. G., and J. Seelig. 1993. Binding of the calcium antagonist
ﬂunarizine to phosphatidylcholine bilayers: charge effects and thermo-
dynamics. Biochem. J. 291:397–402.
Turner, D. C., M. Straume, M. R. Kasimova, and B. P. Gaber. 1995.
Thermodynamics of interaction of the fusion-inhibiting peptide Z-D-Phe-
L-Phe-Gly with dioleoylphosphatidylcholine vesicles: direct calorimetric
determination. Biochemistry. 34:9517–9525.
Tyrrell, D. A., T. D. Heath, C. M. Colley, and B. E. Ryman. 1976. New
aspects of liposomes. Biochim. Biophys. Acta. 457:259–302.
Vane, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of
action for aspirin-like drugs. Nat. New Biol. 231:232–235.
Wenk, M. R., T. Alt, A. Seelig, and J. Seelig. 1997. Octyl-b-d-
glucopyranoside partitioning into lipid bilayers: thermodynamics of
binding and structural changes of the bilayer. Biophys. J. 72:1719–1731.
Wenk, M. R., and J. Seelig. 1998. Magainin-2 amide interaction with lipid
membranes: calorimetric detection of peptide binding and pore
formation. Biochemistry. 37:3909–3916.
Zachowski, A., and P. Durand. 1988. Biphasic nature of the binding of
cationic amphipaths with artiﬁcial and biological membranes. Biochim.
Biophys. Acta. 937:411–416.
954 Matos et al.
Biophysical Journal 86(2) 946–954
